v3.26.1
Stock-Based Compensation
12 Months Ended
Mar. 31, 2026
Stock-Based Compensation [Abstract]  
STOCK-BASED COMPENSATION

NOTE 10 – STOCK-BASED COMPENSATION

 

Stock Options

 

On March 21, 2018, the Board of Directors adopted the Jerash Holdings (US), Inc. 2018 Stock Incentive Plan (the “Plan”), pursuant to which the Company may grant various types of equity awards. 1,484,250 shares of common stock of the Company were reserved for issuance under the Plan. In addition, on July 19, 2019, the Board of Directors approved an amendment and restatement of the Plan, which was approved by the Company’s stockholders at its annual meeting of stockholders on September 16, 2019. The amended and restated Plan increased the number of shares reserved for issuance under the Plan by 300,000, to 1,784,250, among other changes. As of March 31, 2026, the Company had 121,310 shares remaining available for future issuance under the Plan.

 

All stock option activities are summarized as follows:

 

   Option to   Weighted
Average
 
   Acquire
Shares
   Exercise
Price
 
Stock options outstanding as of March 31, 2024   150,000   $6.25 
Granted   
-
    
-
 
Exercised   
-
    
-
 
Expired   
-
    
-
 
Stock options outstanding as of March 31, 2025   150,000   $6.25 

 

   Option to   Weighted
Average
 
   Acquire
Shares
   Exercise
Price
 
Stock options outstanding as of March 31, 2025   150,000   $6.25 
Granted   
-
    
-
 
Exercised   
-
    
-
 
Expired   
-
    
-
 
Stock options outstanding as of March 31, 2026   150,000   $6.25 

All these outstanding options were fully vested and exercisable. As of March 31, 2026, there were 150,000 stock options outstanding. The weighted average remaining life of the options is 2.8 years.

 

Restricted Stock Units

 

On February 9, 2023, the Board of Directors approved the grant of 405,800 RSUs under the Plan to 37 executive officers and employees of the Company, with a two-year vesting period. 405,100 RSUs were vested and additional shares were issued for the fiscal year ended March 31, 2025.

 

On March 25, 2024, the Board of Directors approved the grant of 915,040 RSUs under the Plan to 35 executive officers and employees of the Company, with a three-year vesting period. The fair value of these RSUs on March 25, 2024 was $2,745,120, based on the market price of the Company’s common stock as of the date of the grant. As of March 31, 2026, there were $890,429 unrecognized stock-based compensation expenses to be recognized through March 2027 and 907,840 RSUs remained outstanding.

 

RSU activities are summarized as follows:

 

   Number of
Shares
   Weighted-
Average
Grant
Date Fair
Value Per
Share
 
RSUs outstanding as of March 31, 2024   1,320,140   $3.55 
Granted   
-
    
-
 
Vested   (405,100)   4.78 
Forfeited   (3,600)   3.00 
RSUs outstanding as of March 31, 2025   911,440    3.00 

 

   Number of
Shares
   Weighted-
Average
Grant
Date Fair
Value Per
Share
 
RSUs outstanding as of March 31, 2025   911,440   $3.00 
Granted   
-
    
-
 
Vested   
-
    
-
 
Forfeited   (3,600)   3.00 
RSUs outstanding as of March 31, 2026   907,840    3.00 

 

Total expenses related to the RSUs issued were $904,171 and $1,758,146 for the fiscal years ended March 31, 2026 and 2025, respectively.